- Home
- DGLY vs NLSP Comparison
DGLY vs NLSP Comparison
Compare DGLY & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGLY
- NLSP
- Stock Information
- Founded
- DGLY 2004
- NLSP 2015
- Country
- DGLY United States
- NLSP Switzerland
- Employees
- DGLY N/A
- NLSP N/A
- Industry
- DGLY Radio And Television Broadcasting And Communications Equipment
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- DGLY Technology
- NLSP Health Care
- Exchange
- DGLY Nasdaq
- NLSP Nasdaq
- Market Cap
- DGLY 3.8M
- NLSP 243.8M
- IPO Year
- DGLY N/A
- NLSP 2021
- Fundamental
- Price
- DGLY $1.03
- NLSP $4.55
- Analyst Decision
- DGLY
- NLSP
- Analyst Count
- DGLY 0
- NLSP 0
- Target Price
- DGLY N/A
- NLSP N/A
- AVG Volume (30 Days)
- DGLY 58.4K
- NLSP 33.1K
- Earning Date
- DGLY 11-12-2024
- NLSP 11-01-2024
- Dividend Yield
- DGLY N/A
- NLSP N/A
- EPS Growth
- DGLY N/A
- NLSP N/A
- EPS
- DGLY N/A
- NLSP N/A
- Revenue
- DGLY $23,417,110.00
- NLSP N/A
- Revenue This Year
- DGLY $22.14
- NLSP N/A
- Revenue Next Year
- DGLY N/A
- NLSP N/A
- P/E Ratio
- DGLY N/A
- NLSP N/A
- Revenue Growth
- DGLY N/A
- NLSP N/A
- 52 Week Low
- DGLY $0.84
- NLSP $4.08
- 52 Week High
- DGLY $3.29
- NLSP $29.84
- Technical
- Relative Strength Index (RSI)
- DGLY 46.14
- NLSP 40.59
- Support Level
- DGLY $0.95
- NLSP $4.38
- Resistance Level
- DGLY $1.07
- NLSP $5.64
- Average True Range (ATR)
- DGLY 0.06
- NLSP 0.47
- MACD
- DGLY 0.01
- NLSP 0.06
- Stochastic Oscillator
- DGLY 36.36
- NLSP 29.16
About DGLY Digital Ally Inc.
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.